When should acute kidney injury be diagnosed as being from baseline?

When to Diagnose AKI from Baseline

Acute kidney injury (AKI) should be diagnosed from baseline when serum creatinine increases by ≥0.3 mg/dL (≥26.5 μmol/L) within 48 hours OR increases to ≥1.5 times baseline (which is known or presumed to have occurred within the prior 7 days), OR when urine output falls below 0.5 mL/kg/h for 6 hours. 1

Defining Baseline Creatinine

The baseline creatinine determination is critical and follows this hierarchy: 2

• Use the most recent serum creatinine value obtained within the previous 3 months when available 3, 2
• If multiple values exist within 3 months, use the value closest to hospital admission time 2
• If no previous creatinine value exists, use the admission creatinine as baseline 2

Important Caveats About Baseline Selection

The choice of baseline assessment period significantly impacts AKI detection rates and case severity. Studies show that extending the baseline period from in-hospital only to 12 months preadmission increases AKI incidence from 12.5% to 18.3%, though newly identified cases tend to be milder with lower mortality risk. 4 The discriminative power for mortality prediction improves modestly (C statistic from 0.846 to 0.855) when extending baseline assessment to at least 3 months. 4

For community-acquired AKI (occurring before hospital admission), using a creatinine value from the previous 3 months is essential to avoid missing up to 47% of AKI cases that would be missed if only admission creatinine is used as baseline. 2

Time Frames for AKI Diagnosis

The KDIGO criteria incorporate differential timing that must be understood: 1

• 48-hour window: For the absolute increase criterion (≥0.3 mg/dL rise) 1, 5
• 7-day window: For the relative increase criterion (≥1.5-fold rise from baseline) 1, 5
• Staging occurs over the entire course of AKI regardless of timing 1

Special Populations

Patients with Cirrhosis

In cirrhotic patients, the same KDIGO criteria apply, but urine output criteria should be used cautiously or avoided because these patients are frequently oliguric due to avid sodium retention despite maintaining relatively normal GFR, and diuretic use further confounds interpretation. 6, 2 Therefore, serum creatinine changes become the primary diagnostic criterion in cirrhosis. 6

Patients Without Known Baseline

When no baseline creatinine is available and the patient presents with elevated creatinine but normal kidney structure and a clearly identifiable precipitating event, it is reasonable to assume AKI is present. 2 Alternatively, use the initial creatinine as baseline and monitor for subsequent changes meeting AKI criteria. 2

Avoid using back-calculated creatinine from assumed GFR (e.g., MDRD formula with GFR of 75 mL/min) in cirrhotic patients, as this method is inaccurate in this population, particularly those with ascites. 2

Patients with Chronic Kidney Disease

Both ratio-based (≥1.5-fold increase) and absolute difference-based (≥0.3 mg/dL increase) definitions perform poorly in patients with CKD stages 4 and 5. 4 Different baseline eGFR strata require different minimum creatinine thresholds to predict mortality: 7

• eGFR ≥60 mL/min/1.73 m²: Minimum ≥0.2 mg/dL increase needed
• eGFR 30-59 mL/min/1.73 m²: Minimum ≥0.3 mg/dL increase needed
• eGFR <30 mL/min/1.73 m²: Minimum ≥0.5 mg/dL increase needed

Staging AKI from Baseline

Once AKI is diagnosed, staging is based on the maximum creatinine elevation achieved: 1, 5

• Stage 1: 1.5-1.9 times baseline OR ≥0.3 mg/dL increase
• Stage 2: 2.0-2.9 times baseline
• Stage 3: ≥3.0 times baseline OR creatinine ≥4.0 mg/dL (with acute increase ≥0.3 mg/dL) OR initiation of renal replacement therapy

Stage 1 Heterogeneity

Stage 1 AKI represents a heterogeneous group because only one criterion needs to be met—either a 0.3 mg/dL absolute increase or a 50% relative increase. 1 In cirrhotic patients specifically, Stage 1 should be subdivided into Stage 1A (peak creatinine <1.5 mg/dL) and Stage 1B (peak creatinine ≥1.5 mg/dL), as Stage 1B carries significantly higher mortality risk. 6, 8

Common Pitfalls to Avoid

• Do not require creatinine ≥1.5 mg/dL as a threshold for AKI diagnosis—this outdated criterion misses many cases with significant mortality risk 6
• Do not rely solely on urine output in cirrhotic patients with ascites 6, 2
• Do not use admission creatinine as baseline when prior values are available—this misses community-acquired AKI 2
• Do not apply uniform creatinine thresholds across all baseline kidney function levels—adjust thresholds based on baseline eGFR 7